热门资讯> 正文
Prime Medical在定价1.254亿美元股票发行后股价下跌
2025-07-31 11:51
- Prime Medicine (NASDAQ:PRME) has priced its public offering of 38 million shares at $3.30 each, aiming to raise about $125.4 million before expenses.
- The company has also given underwriters a 30-day option to buy up to 5.7 million more shares.
- Notably, the underwriters will not receive any discounts or commissions with respect to 1.81M shares sold to the Cystic Fibrosis Foundation.
- All shares are being sold by Prime Medicine, and the offering is expected to close around August 1, 2025, pending standard conditions.
- PRME --10.97% after hours to $3.49
- Source: Press Release
More on Prime Medicine
- Prime Medicine: Pressing Forward With Lead Liver Targeting Indications
- Prime Medicine soars as Jones sees it as an acquisition target
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
